CH682322A5 - - Google Patents
Download PDFInfo
- Publication number
- CH682322A5 CH682322A5 CH1651/91A CH165191A CH682322A5 CH 682322 A5 CH682322 A5 CH 682322A5 CH 1651/91 A CH1651/91 A CH 1651/91A CH 165191 A CH165191 A CH 165191A CH 682322 A5 CH682322 A5 CH 682322A5
- Authority
- CH
- Switzerland
- Prior art keywords
- compound
- formula
- physiologically acceptable
- followed
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909012465A GB9012465D0 (en) | 1990-06-05 | 1990-06-05 | Chemical compounds |
| GB919104645A GB9104645D0 (en) | 1991-03-05 | 1991-03-05 | Chemical compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH682322A5 true CH682322A5 (US07122547-20061017-C00273.png) | 1993-08-31 |
Family
ID=26297165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1651/91A CH682322A5 (US07122547-20061017-C00273.png) | 1990-06-05 | 1991-06-04 |
Country Status (25)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9104650D0 (en) * | 1991-03-05 | 1991-04-17 | Glaxo Group Ltd | Medicaments |
| ZA994264B (en) | 1998-07-01 | 2000-01-25 | Warner Lambert Co | Stereoisomers with high affinity for adrenergic receptors. |
| US7232837B2 (en) | 1999-06-29 | 2007-06-19 | Mcneil-Ppc, Inc. | Stereoisomers with high affinity for adrenergic receptors |
| GB0014546D0 (en) | 2000-06-14 | 2000-08-09 | Glaxo Group Ltd | A novel process |
| FR2960153B1 (fr) * | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1618005A1 (de) * | 1966-09-22 | 1971-09-09 | Thomae Gmbh Dr K | Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen |
| EP0021636B1 (en) * | 1979-06-16 | 1982-12-01 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
| GB8426191D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
| GB8603475D0 (en) * | 1986-02-12 | 1986-03-19 | Glaxo Group Ltd | Chemical compounds |
| ES8802416A1 (es) * | 1986-04-15 | 1988-06-01 | Glaxo Group Ltd | Un procedimiento para la preparacion de derivados de dicloroanilina. |
-
1991
- 1991-06-04 DE DE4118293A patent/DE4118293A1/de not_active Withdrawn
- 1991-06-04 ES ES9101342A patent/ES2036920B1/es not_active Expired - Fee Related
- 1991-06-04 KR KR1019910009211A patent/KR920000717A/ko not_active Application Discontinuation
- 1991-06-04 GB GB9111946A patent/GB2244709B/en not_active Expired - Fee Related
- 1991-06-04 MY MYPI91000987A patent/MY106672A/en unknown
- 1991-06-04 DK DK106991A patent/DK106991A/da not_active Application Discontinuation
- 1991-06-04 OA OA60012A patent/OA09501A/xx unknown
- 1991-06-04 AT AT0112891A patent/AT399874B/de not_active IP Right Cessation
- 1991-06-04 FI FI912679A patent/FI912679A/fi not_active Application Discontinuation
- 1991-06-04 CH CH1651/91A patent/CH682322A5/fr not_active IP Right Cessation
- 1991-06-04 CA CA002043850A patent/CA2043850A1/en not_active Abandoned
- 1991-06-04 AP APAP/P/1991/000271A patent/AP251A/en active
- 1991-06-04 IE IE189891A patent/IE911898A1/en unknown
- 1991-06-04 LU LU87945A patent/LU87945A1/fr unknown
- 1991-06-04 FR FR9106741A patent/FR2662691A1/fr active Granted
- 1991-06-04 IL IL98363A patent/IL98363A0/xx unknown
- 1991-06-04 EP EP91305057A patent/EP0460924A1/en not_active Withdrawn
- 1991-06-04 SE SE9101687A patent/SE500706C2/sv unknown
- 1991-06-04 IT ITRM910387A patent/IT1245868B/it active IP Right Grant
- 1991-06-04 AU AU78127/91A patent/AU635424B2/en not_active Ceased
- 1991-06-04 NL NL9100960A patent/NL9100960A/nl not_active Application Discontinuation
- 1991-06-04 GR GR910100242A patent/GR1001309B/el unknown
- 1991-06-04 BE BE9100536A patent/BE1005612A5/fr not_active IP Right Cessation
- 1991-06-04 JP JP3159631A patent/JPH05117236A/ja active Pending
- 1991-06-04 PT PT97858A patent/PT97858A/pt not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1720872B1 (fr) | Derives d'aryl- et d'heteroaryl-piperidinecarboxylates, leur preparation et leur application comme inhibiteurs de l'enzyme faah | |
| FR2545482A1 (fr) | Derives de phenethanolamine | |
| EP1879856B1 (fr) | Derives d'alkyl-, alkenyl- et alkynylcarbamates, leur preparation et leur application en therapeutique | |
| EP1708994B1 (fr) | Derives de type aryloxyalkylcarbamates, leur preparation et leur application en therapeutique | |
| EP0202164B1 (fr) | Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique | |
| EP1753725B1 (fr) | Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique | |
| FR2843964A1 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
| FR2883000A1 (fr) | Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique | |
| EP1546111A2 (fr) | Composes derives de la 2-thiohydantoine et leur utilisation pour le traitement du diabete | |
| US4341793A (en) | Secondary amines and their use in pharmaceutical compositions | |
| EP0051917A1 (en) | Benzofuran ethanolamine derivatives, processes for their preparation, and their use in medicine | |
| EP2077837A2 (fr) | Derives de pyrrolizine, indolizine et quinolizine, leur preparation et leur application en therapeutique. | |
| EP0360685A1 (fr) | "[(diarylméthoxy) alcoyl] - 1 pyrrolidines et piperidines, procédés de préparation et médicaments les contenant" | |
| BE1005612A5 (fr) | Derive de la dichloroaniline. | |
| LU86012A1 (fr) | Nouveaux composes naphtaleniques,leur preparation et leur application comme medicaments | |
| FR2707989A1 (fr) | Nouveaux dérivés de benzylamines silylées, leurs sels, leurs procédés de fabrication et les compositions pharmaceutiques les renfermant. | |
| EP0266246A1 (fr) | Dérivés d'imidazo[4,5-b]pyridinone-2, leur préparation et leur application en thérapeutique | |
| EP1131293A1 (fr) | Derives de 1-aminoethylquinoleine pour le traitement de l'incontinence urinaire | |
| EP1476433B1 (fr) | Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments | |
| FR2726268A1 (fr) | Nouvelles o-arylmethyl n-(thio)acyl hydroxylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent | |
| WO1995029154A1 (fr) | Nouveaux derives de benzylamines, leur procede de fabrication et les compositions pharmaceutiques les renfermant | |
| WO2000063160A1 (fr) | Derives de 2-alcoxy-cyclobutane-3,4-dione leur preparation et leur application en therapeutique | |
| FR2741071A1 (fr) | Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique | |
| EP0125975B1 (fr) | Diphénylazométhines portant une chaîne esterifiée, leur préparation et leur application en thérapeutique | |
| FR2600059A1 (fr) | Derives de l'acide benzoique et leur procede de preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |